Relation of Framingham risk score to subclinical atherosclerosis evaluated across three arterial sites

Roksana Karim1, Howard N Hodis, Robert Detrano

  • 1Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, USA. rkarim@usc.edu

Insights

The Framingham risk score (FRS) may underestimate cardiovascular risk. Subclinical atherosclerosis is common even in low-risk individuals, suggesting FRS alone may not be sufficient for risk assessment.

Area of Science:

  • Cardiovascular Medicine
  • Medical Imaging
  • Preventive Cardiology

Background:

  • The Framingham risk score (FRS) is a standard tool for assessing coronary heart disease (CHD) risk.
  • Limitations of FRS in accurately identifying all at-risk individuals have been noted.
  • Subclinical atherosclerosis represents early stages of cardiovascular disease.

Purpose of the Study:

  • To evaluate the prevalence of subclinical atherosclerosis across different Framingham risk score (FRS) strata.
  • To determine the association between FRS and measures of subclinical atherosclerosis in multiple arterial sites.
  • To assess the utility of combining FRS with vascular imaging for risk stratification.

Main Methods:

  • 498 healthy subjects underwent vascular imaging to detect subclinical atherosclerosis.
  • Coronary artery and aortic calcification, and carotid intima-media thickness were measured.
  • Subclinical atherosclerosis measures were analyzed across low, intermediate, and high FRS categories.

Main Results:

  • Subclinical atherosclerosis was significantly associated with FRS across all measured arterial sites.
  • Prevalence of subclinical atherosclerosis increased with higher FRS categories.
  • Even in the low-risk FRS group, a significant proportion (69%) exhibited subclinical atherosclerosis.

Conclusions:

  • Subclinical atherosclerosis is prevalent across the entire spectrum of FRS, including low-risk individuals.
  • Integrating vascular imaging of atherosclerosis with FRS may improve identification of individuals needing intervention.
  • This approach could enhance targeted lifestyle and medical interventions for cardiovascular disease prevention.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...